Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis - Wikidata - wikimedia - TriplyDB

Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis

Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis

http://www.wikidata.org/entity/Q24670926

about

Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

P2860

Q33696922-36B646BB-F606-4CCF-A798-6CCBCB947B87 Q35122444-04D1F02D-465E-428A-90E0-B753AFCD6070 Q35822578-D3C49F28-FFFB-4A40-9B10-2AF6AE46A30C

P2860

Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis

http://www.wikidata.org/entity/Q24670926

description

1993 nî lūn-bûn

@nan

1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Double-blind, comparative stud ...... rbations of chronic bronchitis

@ast

Double-blind, comparative stud ...... rbations of chronic bronchitis

@en

Double-blind, comparative stud ...... rbations of chronic bronchitis

@nl

type

label

Double-blind, comparative stud ...... rbations of chronic bronchitis

@ast

Double-blind, comparative stud ...... rbations of chronic bronchitis

@en

Double-blind, comparative stud ...... rbations of chronic bronchitis

@nl

prefLabel

Double-blind, comparative stud ...... rbations of chronic bronchitis

@ast

Double-blind, comparative stud ...... rbations of chronic bronchitis

@en

Double-blind, comparative stud ...... rbations of chronic bronchitis

@nl

P1433

Q24670926-56E0A7D8-49E4-4E5C-AEA4-4372CF6259BF

P1476

Q24670926-97690545-DACB-44B6-B6EC-EC11BC115EA0

P2093

Q24670926-0F60DD20-4A0A-45E6-9219-707DEB0BD504

Q24670926-1947F61D-F51E-455E-BBF7-303924D2F9B6

Q24670926-5B2D8D2A-ADE2-47F4-A713-B9D90E0400DF

Q24670926-CDC63D2B-7822-451A-93D7-04F2B4164179

P2860

Q24670926-09833DE5-F26C-467C-8C89-FDE134D49800

Q24670926-0B7C1257-4A96-4F74-AA78-57D9EDFA4E9D

Q24670926-169AA474-787B-43B9-8017-478C32264FCA

Q24670926-22888F3B-DA83-4718-9B4C-BF0D892C068B

Q24670926-375B2FA6-3B23-4CFC-ADC3-FC4E06FE096D

Q24670926-3B509322-E66E-48AF-88C4-21D5048027D8

Q24670926-74FF5770-270A-451D-AED4-2CCD5BC4C5A4

Q24670926-763D2BF9-CF43-4F57-981C-F51AD597D011

Q24670926-7BFCD34F-37AC-46C0-8D85-172F302B5314

Q24670926-A37C033B-C55F-46BF-8DDC-A8558BF3CC7D

P304

Q24670926-F48532C2-3DC8-41C4-AC60-B2D6BCB79C8B

P31

Q24670926-2978D256-05CB-48C3-B133-51E9BCA9A8B6

P356

Q24670926-EE1DFAE8-D8E2-4994-A9A4-D8A7CFBF3B3D

P407

Q24670926-7F5D390C-0C3F-466F-BAA7-3C5945A54E3A

P433

Q24670926-6D33C7F7-F336-4FBD-9EBC-4F75A55103E3

P478

Q24670926-AD5FFEC4-1A5C-42D0-A3BC-75A6D87FC4AD

P577

Q24670926-75C745CA-38DA-4BE4-BCC8-2BF5053D42B4

P698

Q24670926-4D2A40A4-EAC6-4262-A0B7-A9A736B37345

P932

Q24670926-15C75914-32C9-4E04-92F0-65B835244E6E

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Double-blind, comparative stud ...... rbations of chronic bronchitis

@en

P2093

J Focht

http://www.w3.org/2001/XMLSchema#string

M Cesana

http://www.w3.org/2001/XMLSchema#string

R K Rondel

http://www.w3.org/2001/XMLSchema#string

W Klietmann

http://www.w3.org/2001/XMLSchema#string

P2860

Drug interactions with quinolone antibacterials

Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates

The in-vitro activity of two new quinolones: rufloxacin and MF 961

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Rufloxacin once daily in acute exacerbations of chronic bronchitis.

Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration.

Pneumococcal resistance to antibiotics.

Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.

Side-effects of quinolones: comparisons between quinolones and other antibiotics.

New mechanisms of bacterial resistance to antimicrobial agents.

P304

2298-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.37.11.2298

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

1993-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8285609

http://www.w3.org/2001/XMLSchema#string

P932

192382

http://www.w3.org/2001/XMLSchema#string